The global stem cell market size is expected to reach USD 19.13 Billion in 2028 at a CAGR of 8.4% during the forecast period, according to the latest report by Reports and Data. Growing adoption of stem cell therapies to treat chronic and rare diseases, rising number of clinical trials for regenerative medicine globally, and rapid progress in stem cell research are key factors expected to drive market revenue growth over the forecast period. In addition, increasing investment by major pharmaceutical and biotechnology companies, advancements in regenerative medicine, and development of advanced gene editing and tissue engineering techniques are also expected to contribute to revenue growth of the market going ahead.
Stem cells are unspecialized cells that have the ability to develop into different types of cells such as liver cells, muscle cells, and brain cells, among others. Stem cells have remarkable ability of self-renewal in undifferentiated state and can differentiate into various cell types with specific functions under appropriate triggers. Stem cells have played a major role in regenerative medicine, with increasing focus on stem cells of human origin such as adult stem cells, somatic stem cells, and embryonic stem cells. These cells can be used to regenerate human cells, organs, and tissues and have the capability to restore normal function after disease or debilitating injury. During embryonic development, stem cells can form cells of all three germ layers – mesoderm, endoderm, and ectoderm. They play a crucial role in repair system of body and normal turnover of regenerative organs such as skin and blood, and this has boosted their importance in medical therapies for the treatment of various degenerative illnesses.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2981
Increasing investment to accelerate stem cell research, rapid adoption of stem cell therapies for the treatment of chronic and neurodegenerative disorders, and the increasing number of clinical trials across the globe are some key factors expected to drive market growth – Our Expert Review
Recent advancements in stem cell biology and research have enhanced the application scope of stem cell therapy in treating diseases wherein currently available medical therapies have failed to cure, prevent progression, or alleviate symptoms. This is also a key factor expected to contribute to revenue growth of the market over the forecast period. However, ethical issues and political controversies, concerns related to immunity, and stringent regulatory policies associated with stem cell research are some key factors expected to restrain market growth to a certain extent over the forecast period.
Some Key Highlights from the Report:
- Human embryonic stem cells segment is expected to register significant revenue growth over the forecast period owing to increasing use of human embryonic stem cells in regenerative medicine, growing application of ESCs in drug discovery and development, and rising use of ESCs to evaluate toxicity and biological activity of small molecule compounds.
- Cryopreservation segment is expected to account for largest revenue share over the forecast period attributable to increasing preference for cryopreservation of stem cells, availability of cell preparations of consistent quality, and growing ability of cryopreservation offer secure and stable storage to prevent metabolic damages to cells.
- Allogeneic stem cell therapy segment is expected to account for a considerably large revenue share over the forecast period owing to increasing use of allogeneic stem cell transplant to treat hematologic disorders, blood cancers, and immune disorders.
- Regenerative medicine is expected to register robust revenue CAGR over the forecast period attributable to rapid progress in regenerative medicine, increasing focus on expanding therapeutic potential to treat neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease, and growing preference for regenerative medicine as a viable alternative to conventional drug-based therapies.
- North America is expected to account for largest revenue share over the forecast period attributable to increasing investment to boost stem cell research, rapid adoption of stem cell therapies to treat chronic diseases, increasing number of clinical trials, and presence of key market players in the region.
Asia Pacific is expected to lead the market growth over the coming years owing to rapid advancements in the healthcare sector in APAC countries such as India, China, and Japan. North America is anticipated to register the highest market growth over the forecast period attributed to the increasing availability of robust healthcare and clinical settings, legalization of medical marijuana, favorable reimbursement scenario, presence of key market players, and rapid technological advancements in the region.
The growing popularity of over-the-counter medications driving market growth
Growing incidence of acute and chronic diseases and lesser access to advanced medical facilities owing to low disposable income levels are driving the demand for over-the-counter medications. Availability of generic and low-cost alternatives to medical therapies are some other factors playing a major role in driving demand for over-the-counter medications.
Restriction on product launches and R&D activities to hamper the market growth
The imposition of strict government regulations and shortage of funds has put a halt on product launches and R&D activities and is expected to restrain market growth over the forecast period. In addition, the launch of expensive drugs and therapies and increasing regulations regarding safety and approvals are also hampering the market growth.
Competitive Landscape:
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, mergers and acquisitions, collaborations, and joint ventures to gain a robust footing in the market.
Top Companies Profiled in the Report:
Celgene Corporation, Virgin Health Bank, ReNeuron Group plc, Biovault Family, Mesoblast Ltd, Precious Cells International Ltd, Caladrius, Opexa Therapeutics, Inc., Neuralstem, Inc., and Pluristem.
Stem Cells Market Segmentation:
Product Outlook (Revenue, USD Billion; 2018-2028)
- Adult stem cells
- Human embryonic stem cells
- IPS cells
- Very small embryonic like stem cells
Technology Outlook (Revenue, USD Billion; 2018-2028)
- Cell acquisition
- Cell Production
- Cryopreservation
- Expansion and sub-culture
Therapy Outlook (Revenue, USD Billion; 2018-2028)
- Allogeneic Stem Cell Therapy
- Autologous Stem Cell Therapy
Application Outlook (Revenue, USD Billion; 2018-2028)
- Regenerative medicine
- Drug discovery & development
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of the Middle East & Africa)
Frequently asked questions addressed in the report:
- What is the revenue growth rate of the global Stem Cells market over the forecast period?
- What are the major factors driving the growth of the Global Stem Cells Market?
- What are the key challenges impacting the global Stem Cells market growth?
- What are the outcomes of the SWOT Analysis and Porter’s Five Forces Analysis conducted in the report?
Thank you for reading our report. For more details please connect with us and our team will ensure the report is customized to meet all the needs of clients. The report also offers a comprehensive regional analysis and specific countries can be included in the report according to the requirements.
Explore Latest Trending Research Reports By Reports and Data:
3D Printing in Healthcare Market, By Technology Type (Material Extrusion, Photopolymerization, Powder Bed Fusion, Material Jetting, Binder Jetting, Sheet Lamination, Directed Energy Deposition), By Application, By End User (Hospitals and Clinics, Pharmaceutical Companies, Research Institutes), and By Region Forecast to 2028
Ambulatory Surgery Center (ASC) Market Analysis By Type (Hospital-Based Ambulatory Surgery Centers, Free-Standing Ambulatory Surgery Centers, Others) By Specialty, By Treatment, And By Region Forecasts To 2028
Bioresorbable Coronary Stents Market By Product Type (Polymeric, Metallic), By Brand, By Application (Coronary artery disease, Peripheral artery disease), By Absorption Rate, By End User (Hospitals, Surgical Centres, Others) And Region, Forecast 2020 To 2028
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Media Contact
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Phone: +1-212-710-1370
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States
Website: https://www.reportsanddata.com/report-detail/stem-cells-market